Online Referral and Intervention to Prevent Adolescent and Young Adult Suicide

Condition(s) studied

Investigational drug(s) / intervention(s)

ELIOS: ELIOS is a suicide prevention system worldwide entirely tailored to the AYA contemporaneous modes of interaction on social media. This includes * A systematic initial contact with an ELIOS web-clinician * Systematic recontacts by the ELIOS web-clinicians scheduled at 24h, 72h and/or 7 days, depending on the participants' level of suicide risk * The opportunity to spontaneously contact the ELIOS system and get in contact with a web-clinician

other resources contacts: Three types of resources will be suggested via the ELIOS website: * The General Practitioner (GP) * The closest medico-psychologic center (CMP) * The emergency services The order of presentation of the resource contacts will depend on the participants' intensity of suicidal ideation.

Study summary

ORIAS is a randomized controlled trial designed to study the efficacy of the ELIOS system in reducing suicidality in the AYA, reinforcing their motivation to seek help and making them access to care.

As ELIOS would be the first suicide prevention system worldwide entirely tailored to the AYA contemporaneous modes of interaction on social media, ORIAS was designed to address the challenge of deciding whether this innovation is worth adding to the current national and international prevention arsenal. While randomized control trials are crucially lacking in the field of suicide prevention, especially on the Internet, the high-level evidence that ORIAS is expected to bring could have a decisive influence on how the French prevention strategies will seize the social media.

Eligibility

Primary outcome measure(s)

• the change of the intensity of the severest suicidal ideation experienced in the past week by the participants. — from baseline to the 3-months follow-up
  The intensity of suicidal ideation will be measured by the total score on the Intensity of Ideation (IoI) subscale of the Columbia Suicide Severity Rating Scale (C-SSRS)

Trial sites (1)

More University Hospital, Lille trials in France

Other trials for the same condition